Summary
This business provides strategic support to biopharma companies in developing and bringing innovative therapies to market. Their services include establishing regulatory strategies, integrated product development, and navigating clinical trials. They focus on advanced therapies such as cell and gene therapies, vaccines, and orphan drugs, ensuring compliance with regulatory requirements while optimizing market potential. They collaborate closely with regulators, health authorities, and investors to facilitate the drug development process.
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
10.8 years — Since Mar 2014
Web Hosting
Platform
E-Mail Provider
Microsoft Office 365
NAICS Code
541711
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Biotechnology and Pharmaceuticals
2.
Vendor
Source
GlobalSign
TXT Record
Pardot
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|